Volver a Ensayos Clínicos

NCT01507545

Investigación de Morphotek en cáncer colorrectal: estudio de MORAb-004 (MICRO)

Archived Fase 2

Descripción

El objetivo de este estudio es evaluar si la terapia con MORAb-004 es eficaz y segura en el tratamiento del cáncer colorrectal metastásico.

Evidencia de la diana molecular en cáncer colorrectal

Aún no hay evidencia documentada en nuestra base para la diana o el fármaco de este ensayo. Esta sección crece a medida que se procesan nuevas publicaciones.

Criterios de Elegibilidad

Criterios de inclusión:

  • Hombres y mujeres mayores de 18 años
  • Diagnóstico de cáncer colorrectal metastásico
  • Las condiciones médicas significativas deben estar bien controladas y ser estables durante al menos 30 días antes de la primera infusión de tratamiento
  • Estar dispuesto y ser capaz de proporcionar el consentimiento informado por escrito

Criterios de exclusión:

  • No haber recibido tratamiento previo para el cáncer colorrectal metastásico
  • Otras enfermedades sistémicas graves (bacterianas o fúngicas)
  • Enfermedad cardíaca clínicamente significativa o una arritmia en un electrocardiograma en los últimos 6 meses
  • Reacción alérgica conocida a la terapia con anticuerpos monoclonales

Información del Ensayo

NCT01507545
Archived
Fase 2
154 participantes
Mar 2012
Oct 2013

Ubicaciones67

United States (67)
Central Hem/Onc Medical Group, Inc.
Alhambra, California, 91801
Comprehensive Blood and Cancer Center
Bakersfield, California, 93309
Providence St. Joseph Medical Center-Disney Family Cancer Center
Burbank, California, 91505
St. Jude Heritage Healthcare
Fullerton, California, 92835
The Thomas and Dorothy Leavey Cancer Center Northridge Hospital Medical Center
Northridge, California, 91328
UC Davis Comprehensive Cancer Center
Sacramento, California
Sharp Memorial Hospital
San Diego, California, 92123
CPMCRI / Pacific Hematology Oncology Associates
San Francisco, California, 94115
Central Coast Medical Oncology
Santa Maria, California, 93454
UCLA Hematology Oncology
Santa Monica, California, 90404
Colorado Cancer Research Program
Denver, Colorado, 80224
St. Mary's Hospital Regional Cancer Center
Grand Junction, Colorado, 81501
Lutheran Hematology & Oncology
Wheat Ridge, Colorado, 80033
Christiana Care Health Services
Newark, Delaware, 19713
Georgetown University
Washington D.C., District of Columbia, 20007
Integrated Community Oncology Network / Cancer Specialists of North Florida
Jacksonville, Florida, 32256
Mayo Clinic Florida Hematology/Oncology
Jacksonville, Florida, 32224
Compass Research, LLC
Orange City, Florida, 32763
Hematology Oncology Associates of the Treasure Coast
Port Saint Lucie, Florida, 34952
Cancer Care Centers of Brevard
Rockledge, Florida, 32955
H. Lee Moffitt Cancer Center (Moffitt Cancer Center)
Tampa, Florida, 33612
Suburban Hematology-Oncology Associates, P.C.
Duluth, Georgia, 30096
Suburban Hematology-Oncology Assoc., PC
Lawrenceville, Georgia, 30046
Suburban Hematology-Oncology Associates, P.C.
Snellville, Georgia, 30078
Medical and Surgical Specialists
Galesburg, Illinois, 61401
Ingalls Cancer Research Center
Harvey, Illinois, 60426
Oncology Specialists,S.C. Center for Advanced Care
Park Ridge, Illinois, 60068
Illinois CancerCare, P.C.
Peoria, Illinois, 61615
Carle Cancer Center
Urbana, Illinois, 61801
Medical Oncology & Hematology Associates (Clinic #3)
Clive, Iowa, 50325
Iowa Oncology Research Association
Des Moines, Iowa, 50309
Medical Oncology & Hematology Associates (Clinic #1)
Des Moines, Iowa, 50309
Medical Oncology & Hematology Associates (Clinic #2)
Des Moines, Iowa, 50314
Siouxland Hematology-Oncology Associates, LLP
Sioux City, Iowa, 51101
Cancer Center of Kansas
Wichita, Kansas, 67208
Cancer Center of Kansas
Wichita, Kansas, 67214
Central Baptist Hospital
Lexington, Kentucky, 40503
John Hopkins University
Baltimore, Maryland, 21231-1000
Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, 21237
Lahey Clinic
Burlington, Massachusetts, 01805
St. Joseph Mercy Hospital
Ann Arbor, Michigan, 48106
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109
Henry Ford Health System
Detroit, Michigan, 48202
Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, 49503
Essentia Health Duluth CCOP
Duluth, Minnesota, 55805
Mayo Clinic
Rochester, Minnesota, 55905
Coborn Cancer Center/ CentraCare Health Plaza
Saint Cloud, Minnesota, 56303
Metro Minnesota CCOP
Saint Louis Park, Minnesota, 55416
Regions Hospital
Saint Louis Park, Minnesota, 55416
St. John's Hospital
Saint Louis Park, Minnesota, 55416
CCCN
Las Vegas, Nevada, 89169
Roswell Park Cancer Institute
Buffalo, New York, 14263
Mount Sinai Medical Center
New York, New York, 10029
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
Presbyterian Hospital Cancer Center
Charlotte, North Carolina, 28204
Duke University Medical Center
Durham, North Carolina, 27710
Piedmont Hematology Oncology Associates PA
Winston-Salem, North Carolina, 27103
Medcenter One
Bismarck, North Dakota, 58501
TriHealth Oncology Institute/Oncology Partners Network
Cincinnati, Ohio, 45247
Hickman Cancer Center at Flower Hospital
Sylvania, Ohio, 43560
Mercy Cancer Center
Toledo, Ohio, 43623
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
Pharma Resource
East Providence, Rhode Island, 02915
Rhode Island Hospital
Providence, Rhode Island, 02903
The Miriam Hospital
Providence, Rhode Island, 02906
St. Mary's Hospital / Green Bay Oncology
Green Bay, Wisconsin, 54303
St. Vincent Hospital / Green Bay Oncology
Green Bay, Wisconsin, 54301

Fuente Oficial

Ver en ClinicalTrials.gov